- Home
- XBIO vs CREG Comparison
XBIO vs CREG Comparison
Compare XBIO & CREG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XBIO
- CREG
- Stock Information
- Founded
- XBIO N/A
- CREG 1980
- Country
- XBIO United States
- CREG China
- Employees
- XBIO N/A
- CREG N/A
- Industry
- XBIO Biotechnology: Pharmaceutical Preparations
- CREG Power Generation
- Sector
- XBIO Health Care
- CREG Utilities
- Exchange
- XBIO Nasdaq
- CREG Nasdaq
- Market Cap
- XBIO 5.8M
- CREG 6.1M
- IPO Year
- XBIO N/A
- CREG N/A
- Fundamental
- Price
- XBIO $2.53
- CREG $0.56
- Analyst Decision
- XBIO Hold
- CREG
- Analyst Count
- XBIO 1
- CREG 0
- Target Price
- XBIO N/A
- CREG N/A
- AVG Volume (30 Days)
- XBIO 7.1K
- CREG 83.4K
- Earning Date
- XBIO 05-08-2025
- CREG 05-13-2025
- Dividend Yield
- XBIO N/A
- CREG N/A
- EPS Growth
- XBIO N/A
- CREG N/A
- EPS
- XBIO N/A
- CREG N/A
- Revenue
- XBIO $2,500,284.00
- CREG N/A
- Revenue This Year
- XBIO $14.23
- CREG N/A
- Revenue Next Year
- XBIO N/A
- CREG N/A
- P/E Ratio
- XBIO N/A
- CREG N/A
- Revenue Growth
- XBIO N/A
- CREG N/A
- 52 Week Low
- XBIO $2.26
- CREG $0.53
- 52 Week High
- XBIO $5.20
- CREG $1.48
- Technical
- Relative Strength Index (RSI)
- XBIO 25.28
- CREG 31.77
- Support Level
- XBIO $2.26
- CREG $0.67
- Resistance Level
- XBIO $3.43
- CREG $0.81
- Average True Range (ATR)
- XBIO 0.21
- CREG 0.07
- MACD
- XBIO -0.07
- CREG -0.02
- Stochastic Oscillator
- XBIO 16.67
- CREG 0.00
About XBIO Xenetic Biosciences Inc.
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immune-oncology technologies addressing cancers. The company is also engaged in progressing XCART, a personalized CAR T platform technology. The Company's DNase platform is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which have been implicated in cancer progression and resistance to cancer treatments. The company also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin-resistant endometrial cancer.
About CREG Smart Powerr Corp.
Smart Powerr Corp is a pioneer in waste energy recycling and a developer of energy efficiency solutions for various energy-intensive industries in China. It uses the Build-Operate-Transfer (BOT) model to provide energy-saving and recovery facilities for multiple energy-intensive industries in China. Its waste energy recycling projects allow customers which use substantial amounts of electricity to recapture previously wasted pressure, heat, and gas from their manufacturing processes to generate electricity. The company currently offer waste energy recycling systems to companies for use in nonferrous metal plants. It constructs its projects at its customer's facility and the electricity produced is used on-site by the customer.